Venetoclax Combined with Vyxeos (CPX-351) for Participants with Relapsed or Refractory Acute Leukemia

Recruiting

Phase 1

Venetoclax & VyxeosVenetoclax Combined with Vyxeos (CPX-351) for Participants with Relapsed or Refractory Acute Leukemia

Sponsor:

Children's Hospital Medical Center, Cincinnati

Code:

NCT03826992

Conditions

Leukemia

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Vyxeos

Venetoclax

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati on 2025-03-12.